Nathalie Mesnard

Pharma and biotech leaders are rethinking their outsourcing. A new ICON survey reveals why 72% of sponsors plan on adopting blended models in the next 5 years. Learn how these flexible strategies that combine FSP + FSO under one interoperable framework are helping organisations overcome complexity and plan for the future. Download the full report: https://ow.ly/ZvO750WgFQN

86

France’s Early Access system provides a vital route for patients to access innovative therapies ahead of market authorisation, but navigating its complexities requires precision and strategy. Watch nathalie CAIZERGUES, Medical Affairs Director, Europe, at the Clinigen Insights Virtual Week, as she breaks down: • Core requirements of France’s Early Access framework • How to handle exceptions and edge cases with confidence • Proven strategies for smooth and compliant implementation Watch the full session here https://lnkd.in/et6Gg6bP #EarlyAccess #MarketAccess #RegulatoryAffairs #ClinigenInsights #MAP #Pharma #HTA #France

41

Artificial intelligence is no longer a buzzword in life sciences—it’s a business imperative. In IQVIA’s 2025 survey of over 100 senior commercial leaders, one message came through loud and clear: AI is moving from pilot projects to core strategy. Download the full white paper to explore the data, insights, and leadership recommendations: https://lnkd.in/dp5qYf8R

62

Precision medicine is gaining momentum in #pancreaticcancer. By identifying unique features in a patient’s tumor — like rare FGFR2 gene fusions — more personalized treatment options are becoming possible. 🧬🔬 An innovative new clinical trial is now making it easier for patients to participate — no travel required. Learn more in this month’s Research Spotlight with Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer: http://pcan.at/ycilpo

37

With the EU #HTA regulation transforming how innovation reaches patients, companies must rethink strategies to stay ahead. From #PICO landscaping to early HTA integration, success demands collaboration and the right expertise. Hear from Cencora experts Herbert Altmann, Vice President of Market Access and Healthcare Consulting Europe, and Ruairi O’Donnell, EU HTA Lead, as they share actionable strategies to bridge gaps and thrive in this transformative regulatory landscape. 👉 Dive into the full conversation here: https://lnkd.in/ecZ26mDp

49

📢New article on Our Stories!    👨‍💼 What does it mean to be a Pharmaceutical Sales Representative at Santen?  👩‍⚕️ How do they approach their work with patients and doctors?  💎 What makes Santen Sales Representatives unique in the pharmaceutical industry?    In this article, we spoke with Kenji Haruna, Pharmaceutical Sales Representative, who shares his personal journey, daily challenges, and the passion behind his work in ophthalmology. His story highlights how patient-centric thinking and teamwork drive continuous growth and build trust among healthcare professionals and colleagues.    Read the full story here 👉 https://lnkd.in/gEfWg9MG   #Ophthalmology #SalesRepresentative #CareerStories #PatientCentricity #JoinOurTeam #PharmaJobs 

88

1 commentaire

Redefining healthcare: the power of large-volume sterile cartridges. As biologics transition from hospital IV treatments to patient-friendly subcutaneous delivery at home, new solutions are required for administering large-volume injections. That’s where our cartriQ® 5 ml sterile cartridge comes in.   ✅ Made from FIOLAX® CHR Borosilicate Glass, it ensures low leachables, high chemical resistance, and drug stability. ✅ With baked-on silicone, it minimizes free silicone and supports consistent injection performance. ✅ Delivered in a standardized ready-to-use nest and tub format with validated in-house sterilization, it streamlines the fill-and-finish process.   At SCHOTT Pharma, we’re not just innovating - we’re collaborating to transform how biologics are administered. That's why cartriQ® 5 ml has been co-developed with SHL Medical’s Maggie® 5.0 ml autoinjector and is ready for commercial applications. This guarantees seamless compatibility, precise dimensional accuracy, and smooth gliding forces to ensure a safe and comfortable injection experience. Together, SCHOTT Pharma and SHL Medical are bringing large-volume biologics into patients’ hands, making self-administration more reliable, efficient, and patient-centric. Read more about the power of large-volume sterile cartridges here: https://lnkd.in/eZJKzyb3

76

2 commentaires

🔍 How can shared decision-making lead to better osteoporosis care? Clare Carroll, Global Integrated Insights Lead at UCB, highlights why understanding the lived experience of patients and the goals of medical professionals is key to closing care gaps. We’re at #FFN2025 to discuss how shared decision-making can lead to better, more personalized outcomes for people living with osteoporosis. This post is targeted at healthcare professionals. #SharedDecisionMaking #Osteoporosis #BoneHealth #FFN2025 #FragilityFractures #FracturePrevention

82

1 commentaire